Search

The 9th International Conference on Bacteriology and Microbiology 2025 is a globally recognized scientific event bringing together researchers, microbiologists, healthcare professionals, and industry experts to explore the latest advancemen

The American Society for Microbiology (ASM) and the Infectious Diseases Society of America (IDSA) are hosting the Interdisciplinary Meeting on Antimicrobial Resistance and Innovation, taking place on January 28-30, 2026. The conference aims

Evergreen 2025 is happening, and for the first time in its 50-year history, we're taking it on the road! Register for the 26th Biennial Evergreen International Phage Meeting, which will be held August 3-8, 2025, at the University of Tennes

Why don't we have phage therapy yet? We want to understand why. Come join the fun by tuning into the Podovirus podcast! 🎙️ Most recent episode: Dr. Marisa Azad, infectious disease physician at The Ottawa Hospital, shares her experience le

You’re invited to submit an abstract to the inaugural Conference on Bacteriophages: Biology, Dynamics, and Therapeutics, chaired by Graham Hatfull (University of Pittsburgh) and Robert (Chip) Schooley (UCSD). Topics range from phage struct

Tolka AI Therapeutics has announced expanded access to patient-tailored phage therapy for M. abscessus infections. They're screening patients at five institutions for compassionate use where standard antibiotics have failed.

The Global Clinical Phage Rounds (GCPR) is an ongoing forum for discussing phage therapy cases and advances among clinicians and scientists. The organizers (Greg German, Gina Suh, Jon Iredell and colleagues) are excited to announce a speci

You’re invited to submit an abstract to the inaugural Conference on Bacteriophages: Biology, Dynamics, and Therapeutics, chaired by Graham Hatfull (University of Pittsburgh) and Robert (Chip) Schooley (UCSD). Topics range from phage struct

Tolka AI Therapeutics has announced expanded access to patient-tailored phage therapy for M. abscessus infections. They're screening patients at five institutions for compassionate use where standard antibiotics have failed.

You’re invited to submit an abstract to the inaugural Conference on Bacteriophages: Biology, Dynamics, and Therapeutics, chaired by Graham Hatfull (University of Pittsburgh) and Robert (Chip) Schooley (UCSD). Topics range from phage struct

Tolka AI Therapeutics has announced expanded access to patient-tailored phage therapy for M. abscessus infections. They're screening patients at five institutions for compassionate use where standard antibiotics have failed.

You’re invited to submit an abstract to the inaugural Conference on Bacteriophages: Biology, Dynamics, and Therapeutics, chaired by Graham Hatfull (University of Pittsburgh) and Robert (Chip) Schooley (UCSD). Topics range from phage struct

The World Health Organization published a new report on phage therapy evidence, showing phages can enhance antibiotic treatments against resistant bacteria as part of a One Health approach.

Alexander Harms was interviewed on the PhageCast podcast about the Basel Phage Collection, basic science insights from E. coli phages, and how these findings can predict phage traits.

Tolka AI Therapeutics has announced expanded access to patient-tailored phage therapy for M. abscessus infections. They're screening patients at five institutions for compassionate use where standard antibiotics have failed.

Hello, I'm looking for phage cocktails for phage therapy to treat and study Sinusitis infections "Streptococcus pneumoniae Haemophilus influenzae Moraxella catarrhalis Staphylococcus aureus Pseudomonas aeruginosa" Please email on amyl

Hi everyone, I'm a researcher based in Argentina working on a phage-based biocontrol project targeting spoilage bacteria in industrial fermentations, particularly lactic acid bacteria like Lactobacillus plantarum, L. fermentum, and L. brev

Reminder to register for the Phage Protein Meeting, taking place in Ghent, Belgium, on September 10-11, 2025. This interdisciplinary conference will bring together experts working with phage lysins/endolysins, tail fibers, tailspikes, depol

The International Antiviral Society-USA (IAS-USA) is hosting a webinar called 'An Introduction to Bacteriophages: Basic Science and Clinical Applications', taking place on June 30, 2025. This webinar consists of 2 lectures by Graham F. Hat

Hello phage community! 😃 We’re looking for a T-series E. coli K-12 phage (e.g., T2, T4, T7) engineered to express a red fluorescent protein (e.g., mCherry) fused to a capsid or tail protein — to track intact virions by microscopy. No induc